SUVEN LIFE SCIENCES LTD. - 530239 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice, seeking approval of Members of the Company, for appointment of Dr. Vajja Sambasiva Rao (DIN: 09233939) as an Independent Director of the Company. SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement - unaudited financial results of the Company for quarter ended 31st December, 2023 SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Deviation(S) Or Variation(S) For Quarter Ended 31St December, 2023 Under Regulation 32 Of SEBI (LODR) Regulations, 2015.
Please find enclosed statement for the quarter ended 31st December, 2023, confirming that there were no deviation(s) of variation(s) in the use of proceeds, from the objects for which funds were raised the rights issue of the Company. SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Dr. Vajja Sambasiva Rao as Non-Executive Additional Independent Director of the Company and noting of resignation of Shri Gopalakrishna Muddusetty as Non-Executive Independent Director of the Company. SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Outcome for Outcome Of The Board Meeting
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we hereby inform that the Board of Directors of Suven Life Sciences Limited at its meeting held today i.e., January 30, 2024, has inter alia, transacted the following businesses: - SUVEN LIFE SCIENCES LTD. - 530239 - Un-Audited Standalone And Consolidated Financial Results Under Ind AS For Quarter And Ended December 31, 2023
Outcome of the Board Meeting Q3 Results FY 2023-24 SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Board Meeting Of The Company To Be Held On Tuesday, January 30, 2024
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 ,inter alia, to consider and approve to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter ended December 31, 2023 and other business matters. SUVEN LIFE SCIENCES LTD. - 530239 - Clarification On Price Movement
Clarification on Price Movement SUVEN LIFE SCIENCES LTD. - 530239 - Clarification sought from Suven Life Sciences Ltd
The Exchange has sought clarification from Suven Life Sciences Ltd on January 12, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificates in terms of Regulation 74(5) of SEBI (DP) Regulations